Table of Contents Table of Contents
Previous Page  61 / 89 Next Page
Information
Show Menu
Previous Page 61 / 89 Next Page
Page Background

Volume 6, Issue 6(Suppl)

J Clin Toxicol 2016

ISSN: 2161-0495, JCT an open access journal

Page 102

Notes:

Euro Toxicology 2016

October 24-26, 2016

conferenceseries

.com

Toxicology & Applied Pharmacology

October 24-26, 2016 Rome, Italy

7

th

Euro-Global Summit on

Nutraceuticals for hypertension care: A network based approach

Matteo Micucci, Chiarini A

and

Budriesi R

University of Bologna, Italy

S

everal diseases with a high incidence including those pertaining cardiovascular system, are due to modifications of many

molecular networks influencing each other’s. The network based approach is based on the strategy named “network target

multi components” and “network target single chemical” strategies. In different traditional systems, including Traditional

Chinese Medicine (TCM) and ayurveda, poly-herbal formulations are considered efficient approaches to the treatment of

multifactorial diseases. Nutraceutical science is mainly aimed at identifying the chemical composition and the mechanisms of

action of complex mixtures, including the vegetal extracts. In this study, we focused on primary hypertension, representing a

multifactorial pathology strongly predisposing to cardiovascular events. Many vegetal extracts with antihypertensive activities

modulate several targets determining multiple cardiovascular beneficial effects. Among others, extracts from

Olea europaea

L.

leaves and

Hibiscus sabdariffa

L.

flowers interfere with different pathways, producing a hypotensive activity. In this work,

we evaluated the cardiovascular effects and the toxicological profile of a Nutraceutical Formulation (NF) based on a mixture

of a

Olea europaea L.

leaves extract (OEE) and a

Hibiscus sabdariffa L.

flowers extract (HSE) in the ratio of 13:2 using

in vitro

biological assays. The NF exerted a vasorelaxant effect (IC50=2.38mg/mL) and a negative chronotropic effect (IC50=1.04mg/

mL) at concentrations lower than those producing smooth muscle spontaneous contractility alterations in the other organs.

These experimental data suggest a potential application of this food supplement for contributing and managing preclinical

hypertension.

Biography

Matteo Micucci completed his graduation in Pharmacy at Bologna University. In 2010, he worked in the laboratory of Dr. RRJ Arroo, Leicester School of Pharmacy,

De Montfort University, UK. He was a Guest Scientist in the Department of Chemistry of Natural Substances, University of Naples “Federico II”, Italy. He awarded

European PhD in Pharmaceutical Sciences at Bologna University in 2012. He is a Scientific Consultant, in the field of Nutraceutical, Alternative and Complementary

Medicines, at Segreteria Particolare of a Senator of the Italian Republic. He is a Research Fellow Scientist at Department of Pharmacy and Biotechnology,

University of Bologna.

matteo.micucci2@unibo.it

Matteo Micucci et al., J Clin Toxicol 2016, 6:6(Suppl)

http://dx.doi.org/10.4172/2161-0495.C1.021